Skip to main content
Stem Cells Translational Medicine logoLink to Stem Cells Translational Medicine
. 2022 Dec 24;12(2):123. doi: 10.1093/stcltm/szac085

Correction to: Pluripotent Stem Cell-Based Screening Identifies CUDC-907 as an Effective Compound for Restoring the In Vitro Phenotype of Nakajo-Nishimura Syndrome

PMCID: PMC9985107  PMID: 36565066

This is a correction to: Naoya Kase, Madoka Terashima, Akira Ohta, Akira Niwa, Fumiko Honda-Ozaki, Yuri Kawasaki, Tatsutoshi Nakahata, Nobuo Kanazawa, Megumu K. Saito, Pluripotent stem cell-based screening identifies CUDC-907 as an effective compound for restoring the in vitro phenotype of Nakajo-Nishimura syndrome, Stem Cells Translational Medicine, Volume 10, Issue 3, March 2021, Pages 455–464, https://doi.org/10.1002/sctm.20-0198

The original versions of Figures 3B and 3H contained errors in the statistical analysis methods; these data have been corrected by one-way analysis of variance. These corrections do not affect the results and conclusions of the paper. The corrected versions of Figures 3B and 3H are published here. These details have been corrected only in this correction notice to preserve the published version of record.

graphic file with name szac085f0001.jpg


Articles from Stem Cells Translational Medicine are provided here courtesy of Oxford University Press

RESOURCES